» Authors » Yusuke Miyazato

Yusuke Miyazato

Explore the profile of Yusuke Miyazato including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 494
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Maruki T, Ishikane M, Kurokawa M, Kubo T, Miyazato Y, Ohmagari N
Jpn J Infect Dis . 2025 Jan; PMID: 39756960
Guidelines for sexually transmitted infections recommend oral metronidazole (MNZ) as the first-line treatment option for vaginal trichomoniasis; however, there have been cases of prolonged symptoms or recurrence after treatment. To...
2.
Kuwano T, Kanno T, Tobiume M, Hirata Y, Katano H, Koga M, et al.
Sci Rep . 2024 Oct; 14(1):26057. PMID: 39472469
There have been several reports of skin manifestations in patients with coronavirus disease 2019 (COVID-19). However, it is unclear whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA can be...
3.
Nakamoto T, Iwamoto N, Oshiro Y, Inamura N, Nemoto T, Ide S, et al.
BMC Infect Dis . 2024 Oct; 24(1):1197. PMID: 39443853
Background: Dexamethasone is currently administered for Coronavirus disease 2019(COVID-19); however, there are concerns about its effect on specific antibodies' production. The aim of this study was to evaluate whether specific...
4.
Maruki T, Morioka S, Miyazato Y, Tsuzuki S, Takezawa K, Kuribayashi S, et al.
J Infect Chemother . 2024 Jun; 30(11):1194-1196. PMID: 38944382
Some reports suggest that coronavirus disease 2019 (COVID-19) may affect male reproductive function. There is also concern in Japan that COVID-19 may contribute to the pre-existing decline in male fertility;...
5.
Miyazato Y, Tsuzuki S, Matsunaga A, Morioka S, Terada M, Saito S, et al.
Glob Health Med . 2023 May; 5(2):106-111. PMID: 37128226
The symptoms that persist after an acute coronavirus disease 2019 (COVID-19) are referred to as post- COVID conditions. Although the cause of post-COVID conditions remains unclear, the host immune response...
6.
Uchihara M, Kodani N, Bouchi R, Saito S, Miyazato Y, Sugimoto H, et al.
Glob Health Med . 2023 Jan; 4(6):336-340. PMID: 36589220
In patients with severe coronavirus disease 2019 (COVID-19) with diabetes, glycemic control is essential for a better outcome, however, we face difficulty controlling hyperglycemia induced by high-dose glucocorticoids. We report...
7.
Kanayama S, Nagata S, Akiyama Y, Miyazato Y, Ishikane M, Inoue M, et al.
Br J Neurosurg . 2022 Dec; 38(6):1283-1288. PMID: 36564899
Background: Cerebral syphilitic gummas are rare. However, numerous case reports on them have been published recently, consistent with the resurgence of syphilis and its accompanying atypical manifestations. We here present...
8.
Miyazato Y, Iwamoto N, Usui M, Sato T, Miyoshi-Akiyama T, Nagashima M, et al.
BMC Infect Dis . 2022 Sep; 22(1):762. PMID: 36180829
Background: Polymyxin E (colistin) is a last-resort antibiotic to treat infections caused by carbapenemase-producing Enterobacteriaceae (CPE). However, reports of CPEs resistant to colistin have been increasing, and the mcr genes...
9.
Nomoto H, Yamamoto K, Isaka E, Miyazato Y, Suzuki T, Maruki T, et al.
J Infect Chemother . 2022 Sep; 29(1):15-19. PMID: 36089257
Introduction: Anterior nasal sampling (AN) might be more convenient for patients than NP sampling to diagnose coronavirus disease. This study investigated the feasibility of rapid antigen tests for AN sampling,...
10.
Goto R, Kawakami H, Horiuchi Y, Chikada A, Yasuda T, Suzuki T, et al.
Intern Med . 2022 Sep; 61(22):3439-3444. PMID: 36070957
We herein report a case of cerebral infarct in a patient with coronavirus disease 2019 (COVID-19) infection who died of aspiration pneumonia. The postmortem examination of the brain revealed embolic...